Literature DB >> 9786582

Successful surgical treatment for hepatic encephalopathy caused by a pancreatic siphon: report of a case.

H Nozaki1, T Shimada, Y Fukushima, T Inou, Y Takeda.   

Abstract

We report herein the case of a 39-year-old man with cirrhosis of the liver who developed hepatic encephalopathy and progressive diabetes caused by a pancreatic siphon after undergoing a distal splenorenal shunt (DSRS) for a variceal hemorrhage. Radiologic occlusion was judged to be inappropriate because of the extensive DSRS. The DSRS was surgically closed 6 years after the operation to restore portal perfusion. To alleviate the portal hypertension, splenectomy and gastric devascularization were performed, which proved successful, as the encephalopathy disappeared completely, the ammonia levels decreased, liver function improved, and the diabetes subsided. Our experience indicates that a small percentage of cirrhotic patients who undergo DSRS with longterm followup may develop various undesirable complications, although some of these patients benefit from a combination of surgical shunt occlusion, splenectomy, and gastric devascularization.

Entities:  

Mesh:

Year:  1998        PMID: 9786582     DOI: 10.1007/BF02483964

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

1.  The effect upon the liver of evisceration with or without hormone replacement.

Authors:  T E Starzl; A Francavilla; K A Porter; J Benichou
Journal:  Surg Gynecol Obstet       Date:  1978-04

2.  Selective variceal decompression after splenectomy or splenic vein thrombosis. With a note on splenopancreatic disconnection.

Authors:  W D Warren; W J Millikan; J M Henderson; M E Rasheed; A A Salam
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

3.  A shunt equation for estimating the splenic component of portal hypertension.

Authors:  L R Del Guercio; J D Cohn; K K Kazarian; M Kinkhabwalla
Journal:  Am J Surg       Date:  1978-01       Impact factor: 2.565

4.  Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts.

Authors:  S S Hanna; R S Smith; J M Henderson; W J Millikan; W D Warren
Journal:  Am J Surg       Date:  1981-08       Impact factor: 2.565

5.  Intraportal insulin protects from the liver injury of portacaval shunt in dogs.

Authors:  T E Starzl; K A Porter; C W Putnam
Journal:  Lancet       Date:  1975-12-20       Impact factor: 79.321

6.  Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt.

Authors:  W D Warren; R Zeppa; J J Fomon
Journal:  Ann Surg       Date:  1967-09       Impact factor: 12.969

Review 7.  [Etiology and hemodynamics of esophago-gastric varices].

Authors:  A Hasumi; H Aoki; J Fujita; H Sugenoya; A Sugioka; Y Komori
Journal:  Nihon Geka Gakkai Zasshi       Date:  1996-01

8.  Chronic portosystemic encephalopathy: embolization of portosystemic shunts.

Authors:  R Uflacker; A de O Silva; L A d'Albuquerque; R L Piske; G S Mourão
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

9.  Loss of selectivity of Warren shunt in long-term observation.

Authors:  T Isomatsu
Journal:  Jpn J Surg       Date:  1983-05

10.  Long-term evaluation of distal splenorenal shunt with splenopancreatic and gastric disconnection.

Authors:  S Kanaya; H Katoh
Journal:  Surgery       Date:  1995-07       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.